Newsroom
SNT Biotech
in the news.
Coverage, announcements, and insights on our mission to bring at-home screening to the members who need it most.
Coverage, announcements, and insights on our mission to bring at-home screening to the members who need it most.
SNT Biotech announced a partnership with Waters Corporation to bring the FDA-cleared BD Onclarity HPV self-collection kit for at-home cervical cancer screening to patients and health plans across the U.S.
Read the announcement →
Founder and CEO Shital Daftari was featured on NBC 5 Chicago's "Tech Trends," discussing how SNT Biotech helps more women complete cervical cancer screening from home.
Watch the segment →Founder and CEO Shital Daftari was quoted in 360Dx, a GenomeWeb publication, on why health plans are central to HPV self-collection uptake: “just having an FDA-approved test is not enough.”
Read the article →
SNT Biotech was recognized among Chicago's fastest-growing companies by Crain's Chicago Business, reflecting the momentum behind its at-home screening platform.
Read the announcement →
The Women Presidents Organization ranked SNT Biotech No. 6 on its 2022 list of the 50 Fastest-Growing Women-Owned/Led Companies, in partnership with JPMorgan Chase.
Read the announcement →
SNT Biotech founder and CEO Shital Daftari was named a finalist for the EY Entrepreneur Of The Year 2022 Midwest Award, honoring the region's leading entrepreneurs.
Read the announcement →
SNT Biotech founder and CEO Shital Daftari was recognized as one of the Daily Herald's Influential Women in Business.
Read the article →5,000 kits mailed, 1,205 completed screenings, a 24% return rate, and 19 members who had polyps removed. See how we ran it for a regional health plan.
Read the case study →Practical reads on at-home screening, HEDIS and Star measures, member engagement, and closing care gaps at population scale.
Visit the blog →SNT Biotech is a population health technology and diagnostic screening company headquartered in Plainfield, Illinois. It partners with Medicaid, Medicare Advantage, and commercial health plans to close preventive care gaps through fully integrated at-home screening for cervical, colorectal, diabetes, and kidney health, processed in its own CLIA and COLA accredited laboratory. SNT Biotech is an Inc. 5000 company and a certified minority and women-owned business.
We are happy to provide interviews, data, and a clinician spokesperson.
The information on this page is provided for general informational purposes for health plans, employers, providers, and partners. It is not medical advice and is not a substitute for diagnosis, treatment, or the judgment of a qualified healthcare professional. Individuals should discuss screening decisions with their own healthcare provider.
Program results described on this site reflect specific engagements and are not a guarantee or prediction of results any other organization will achieve. Outcomes vary with population, program design, and other factors. Program, test, and service availability varies by state, health plan, and member eligibility, and descriptions are subject to change.
HEDIS is a registered trademark of the National Committee for Quality Assurance (NCQA). All other trademarks are the property of their respective owners and are used for identification purposes only. Reference to a third-party product, partner, or organization does not imply its endorsement of SNT Biotech.